Jump to ContentJump to Main Navigation

Online

Open Access
* Prices subject to change. Shipping costs will be added if applicable.
ISSN:
2084-767X

Invertebrate Immunity

1 Issue per year

VERSITA

VERSITA Emerging Science

Open Access

Invertebrate Immunity is an international journal dedicated in publishing high quality articles in invertebrate immunology research. It covers topics related to: 

  • Innate immunity;
  • Immune receptors and pattern recognition;
  • Cellular and humoral immune responses to bacteria, fungi, viruses, parasites and parasitoids;
  • Effectors immune defenses;
  • Immune priming;
  • Evolutionary basis of immunity;
  • Ecological aspects of immune mechanisms;
  • Molecular immune pathways and signal transduction;
  • Regulation of the immune response;
  • Pathogen evasion strategies and immune responses;
  • Effects of endosymionts on immunity;
  • Infection and pathological effects;

It publishes research articles, communications, reviews and mini-reviews, commentaries and letters to the Editor.

Aims and Scope

Why subscribe and read

  • The first open-access journal devoted to invertebrate immunity research,
  • Reports all the latest cutting edge research finding in invertebrate infection and immunity,
  • High quality peer-reviewed publications.

Why submit 

  • Papers published in open access receive wide readership,
  • Precise and fast peer review process,
  • No page charges .

Instructions for Authors

Editorial Policy

Scope

Invertebrate immunity is devoted to the publication of research in all areas/of innate immunity of invertebrates. Please see our Aims and Scope for details. The primary mission of the journal is to become the central publication venue for all members of the researcher community in Invertebrate immunity. The journal is peer-reviewed, publishes in electronic format only and on ongoing basis (no issues). The language of the journal is English.

Manuscripts

Manuscripts should be submitted to Invertebrate immunity via online submission system Editorial Manager

Manuscript submitted to this journal should:

  • contain original work - not published elsewhere in any medium (in whole or in part) by the authors or anyone else and not under consideration for publication in any other medium;
  • focus on the aims and scope of the journal;
  • be precisely written - should contain all essential features of a scientific publication that is easy to understand for the target audience;
  • written in English - attention to detail of the language will avoid severe misunderstandings which might lead to rejection of the paper;
  • be submitted in electronic format. 

The journal publishes:

  • Research Articles
  • Communications and Rapid Communications
  • Reviews and Mini-Reviews
  • Commentaries
  • Letters to the Editor and Amendments 

Formatting Requirements

Our contributors are asked to ensure their submissions comply with formatting rules. Although the journal can provide limited technical support, it is ultimately the responsibility of the author to deliver a properly formatted electronic version of the article.

Please carefully follow the guidelines described in Instructions for Authors.

Overview of the Editorial Process

The whole peer-review workflow is performed in the Editorial Manager online system.

Submission

Each manuscript should be accompanied by a cover letter which should explicitly state that the authors have the authority to publish the work and that the manuscript (or one with substantially the same content, by any of the authors) has not been previously published in any language anywhere and that it is not under simultaneous consideration by another journal. All authors of the manuscript are responsible for its content; they must have agreed to its publication and have given the corresponding author the authority to act on their behalf in all matters pertaining to publication. The corresponding author is responsible for informing the coauthors of the manuscript status throughout the submission, review, and production process.

Peer Review Process

Each manuscript after uploading to the Editorial Manager receives individual identification code that is used in all correspondence with regard to the publication process. However a submission may be declined by the Editor without review, if the studies reported are not sufficiently novel or important to merit publication in the journal. Manuscripts deemed unsuitable (insufficient originality or limited interest to the target audience) are returned to the author(s) without a review. The Editor may appoint an Associate Editor with expertise in the relevant field, who is fully responsible for further handling the manuscript and for making an ultimate decision about its acceptance/rejection.

a) choice of reviewers

The Editor seeks advice from experts of in the appropriate field. Research articles and communications are refereed by a minimum of two reviewers, review papers by at least three.

b) suggestions from authors

Authors are requested to suggest researchers competent to review their manuscript. However, please note that this will be treated only as a suggestion; the final selection of reviewers is exclusively the Editor's decision. The authors’ names are revealed to the referees, but not vice versa.

The reviewers make an objective, impartial evaluation of scientific merits of the manuscript. Reviewers operate under guidelines set forth in Guidelines for reviewers and are asked to comment on the following aspects of submitted manuscripts:

  • novelty and originality of the work;
  • broad interest to the community of researchers;
  • significance to the field, potential impact of the work, conceptual or methodological advances described;
  • study design and clarity;
  • rigorous methodology;
  • appropriate analysis of data;
  • substantial evidence supporting claims and conclusions;
     

If a manuscript does not meet the standards of the journal, lacks scientific rigor or contains major deficiencies, the reviewers will attempt to provide constructive criticism to assist the authors in ultimately improving their work. If a manuscript is potentially considered acceptable for publication but needs to be improved, it is invited for reconsideration with the expectation that the authors will fully address the reviewers’ suggestions.

Once all reviews have been received and considered by the Editor, a decision letter to the corresponding author is drafted. The types of decisions may be:

  • Accept without revision
  • Minor revision
  • Major revision
  • Reject 

Revised manuscript submission

When revision of a manuscript is requested, authors should return the revised version of their manuscript as soon as possible. Prompt action may ensure fast publication if a paper is finally accepted for publication. If it is the first revision of an article, authors need to return their revised manuscript within 28 days. If it is the second revision, authors need to return their revised manuscript within 14 days. If these deadlines are not met, and no specific arrangements for completion have been made with the Editor, the manuscript will be treated as a new submission and will receive a new identification code along with a new registration date.

Final decision is made by the Editor.

Final proofreading

Authors will receive a pdf file with the edited version of their manuscript for final proofreading. This is the last opportunity to view the article before its publication on the journal web site. No changes or modifications can be introduced once it is published. Thus authors are requested to check their proof pages carefully against the manuscript within 3 working days and prepare a separate document containing all changes that should be introduced. Authors are sometimes asked to provide additional comments and explanations in response to remarks and queries from the language or technical editors.

Immediate publication

Because the journal has no issues, manuscripts accepted for publication are immediately published online (that is when final proofreading is completed by the authors, and all concerns are resolved). Once a manuscript appears on the journal’s web site, it is considered as published.

Reprints

Because the journal is published in Open Access model, without a printed version, the authors receive no reprints.

Erratum

If any errors are detected in the published material, they should be immediately reported to the Editor. The corresponding author should send appropriate corrected material to the Editor via email. This material will be considered for publication as soon as feasible.

Copyright

All authors retain copyright, unless – due to their local circumstances – their work is not copyrighted. The non-commercial use of each article will be governed by the Creative Commons Attribution-NonCommercial-NoDerivs license. The corresponding author grants Versita the exclusive license to commercial use of the article, by signing the License to Publish. Scanned copy of the license should be sent by e-mail to the Editor of Invertebrate Immunity, as soon as possible.

Scientific misconduct and other fraud

Scientific misconduct is defined by the Office of Research Integrity as "fabrication, falsification, plagiarism, or other practices that seriously deviate from those that are commonly accepted within the academic community for proposing, conducting, or reporting research". In cases where there is a suspicion or allegation of scientific misconduct or fraudulent research in manuscripts submitted or published, the Editors reserve the right to impose sanctions on the authors, such as:

  • an immediate rejection of the manuscript;
  • banning author(s) from submitting manuscripts to the journal for a certain period of time;
  • retracting the manuscript;
  • alerting editors of other journals and publishers;
  • bringing the concerns to the authors' sponsoring or funding institution or other appropriate authority for investigation 

Invertebrate Immunity publishes only original manuscripts that are not also published or considered for publication elsewhere. Multiple submissions/publications, or redundant publications (re-packaging in different words of data already published by the same authors) will be rejected. If they are detected shortly after publication, the journal reserves the right to publish a Retraction Note.

Retraction Policy

Serious errors in a published manuscript and infringements of professional ethical codes will result in an article being retracted. This will occur where the article is clearly defamatory, or infringes others' legal rights, or where the article is, or there is good reason to expect it will be, the subject of a court order, or where the article, if acted upon, might pose a serious health risk. In any of these cases all coauthors will be informed about the retraction. A Retraction Note detailing the reason for retraction will be linked to the original article.

[in medical, biomedical and some chemical journals, special provisions on use of experimental animals and human subjects, and also on conflict of interests are necessary]

Use of experimental animals and human subjects

Submission of a manuscript to Invertebrate Immunity implies that any experimental research that is reported in the manuscript has been performed with the approval of an appropriate ethics committee. Manuscripts may be rejected if the Editor considers that the research has not been carried out within an ethical framework. Research involving human participants must be in compliance with the Helsinki Declaration, and any experimental research on animals must follow internationally recognized guidelines. A statement to this effect must appear in the Experimental Procedures section of the manuscript, including the name of the body which gave approval, with a reference number where appropriate. No identifying information should be published for human subjects unless the information is essential for scientific purposes and the patient gives written Informed Consent for publication. Information about Informed Consent obtained from participants should be indicated in the published article. We encourage authors to submit a sample of a patient consent form, and may require submission on particular occasions.

See Instructions for Authors for further details.

Conflicts of Interest

In order to encourage transparency without impeding publication, all authors, referees and editors must declare any association that poses a conflict of interest in connection with the manuscript. There should be no contractual relations or proprietary considerations that would affect the publication of information contained in a submitted manuscript. A competing interest for a scholarly journal is anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, review, or publication of research findings, or of articles that comment on or review research findings. Potential conflicts of interest occur when an author, editor or reviewer has financial, personal or professional interests in a publication that might influence their scientific judgment.

Examples of such conflicts include, but are not limited to:

  • Financial conflicts: stock ownership; patents; paid employment or consultancy; board membership; research grants; travel grants and honoraria for speaking or participation at meetings; gifts
  • Personal conflicts: relationship with editors, editorial board members, or with possible reviewers who have had recent or ongoing collaborations with the authors, have commented on drafts of the manuscript, are in direct competition, have a history of dispute with the authors
  • Professional conflicts: public associations with institutions or corporations whose products or services are related to the subject matter of the article; membership of a government advisory council/committee; relationship with organizations and funding bodies 

Authors should declare whether they have any conflicts of interests that could have influenced the reporting of the experimental data or conclusions in their paper. Such a statement should list all potential interests or, if appropriate, should clearly state that there are none. The Editor may decide not to publish papers when he considers the competing interests are such that they may have compromised the work or the analyses or interpretations presented. Upon submission of a manuscript, authors may suggest to exclude any specific editors or reviewers from the peer review process of their article. It is the responsibility of authors to disclose in the Acknowledgments section any funding sources for supporting the project or other relationships that are relevant.

Editors should consider whether any of the above competing interests are relevant to them and the manuscript under consideration. Editor who believes that the conflict will preclude an impaired judgment should decline to handle the paper.

Reviewers should consider whether any of the above applies to them and declare any such competing interests. If they feel they cannot review a paper because of any competing interest, they should immediately inform the Editor. They should also declare any association with the authors of a paper.

Submission to Invertebrate Immunity

Please submit your manuscripts to Invertebrate Immunity via email to

Ioannis Eleftherianos
ieleftherianos@versita.com

Celdes, CNPIEC, EBSCO Discovery Service, Google Scholar, Microsoft Academic Search, Naviga (Softweco), Primo Central (ExLibris), ProQuest - The Summon, WorldCat (OCLC)

Journal Editor
Ioannis Eleftherianos, The George Washington University

Editorial Advisory Board
Serap Aksoy, Yale University, USA
Sassan Asgari, University of Queensland, Australia
Carolina Barillas-Mury, National Institutes of Health, USA
Sara Cherry, University of Pennsylvania, USA
George Christophides, Imperial College, UK
George Dimopoulos, John Hopkins University, USA
Marc Dionne, King’s College, UK
Angela E Douglas, Cornell University, USA
Jean-Michel Drezen, CNRS, France
Ylva Engström, Stockholm University, Sweden
Jean-Michel Escoubas, INRA, France
Jay Evans, USDA, USA
Jonathan Ewbank, CIML, France
Salvador Herrero, University of Valencia, Spain
Jules Hoffmann, IBMC, UPR9022-CNRS, France
Marie-Odile Fauvarque, CEA, France
Shubha Govind, The City College of CUNY, USA
David Gubb, CIC bioGUNE, Spain
Dan Hultmark, Umeå University, Sweden
John Jaenike, University of Rochester, USA
Haobo Jiang, Oklahoma State University, USA
Francis Jiggins, University of Cambridge, UK
Karyn Johnson, University of Queensland, Australia
Fotis Kafatos, Imperial College, UK
Franҫois Leulier, IBDML, France
Elizabeth McGraw, Monash University, Australia
Kristin Michel, Kansas State University, USA
Darren Obbard, University of Edinburgh, UK
Joao Pedra, UC Riverside, USA
Alexander Raikhel, UC Riverside, USA
Mika Rämet, University of Tampere, Sweden
Stuart Reynolds, University of Bath, UK
Jens Rolff, University of Sheffield, UK
Julien Royet, IBDML, France
Todd Schlenke, Emory University, USA
Neal Silverman, University of Massachusetts Medical School, USA
Mike Siva-Jothy, University of Sheffield, UK
David Stanley, USDA, USA
Michael Strand, University of Georgia, USA
Olle Terenius, Swedish University of Agricultural Sciences, Sweden
Ulrich Theopold, Stockholm University, Sweden
Tina Trenczek, Justus Liebig University, Germany
Andreas Vilcinskas, Justus Liebig University, Germany
Louisa Wu, University of Maryland, USA

Assistant Editors
Julio Castillo, The George Washington University, USA
Stanislava Chtarbanova, University of Wisconsin-Madison, USA

Contact
Ioannis Eleftherianos
ieleftherianos@versita.com 

Versita Ltd.
Ul. Solipska 14a/1
02-482 Warsaw, Poland
Phone: +48 22 701 50 15

Please log in or register to comment.